SEC Form 4 · accession 0001181431-15-007388
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Mildenberger
Officer — Chief People Ofcr, Kidney Care
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 20,000 | $43.35 | A | 26,273 | D | |
| Common Stock | May 20, 2015 | F | 10,421 | $83.20 | D | 15,852 | D | |
| Common Stock | May 20, 2015 | S | 9,579 | $83.15 | D | 6,273 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF1 | $43.35 | May 20, 2015 | M | 20,000 | D | Apr 13, 2014 | Apr 13, 2016 | Common Stock | 20,000 | 7,300 | D |
Explanation of responses
- F1Stock Appreciation Rights granted on 4/13/2011 and vesting 50% each on 4/13/2014 and 4/13/2015.